Guotai CSI Medical Service ETF (159828) Rises 3.26%, Sees Net Inflow of 30.1644 Million Yuan Over the Past 5 Trading Days
NewTimeSpace News, as of 13:14 on May 21, 2026, Guotai Medical ETF (159828) rose 3.26%, with its latest quoted price at 0.41 yuan. (The stocks listed above are merely index constituents and do not constitute any specific recommendation.)
In terms of liquidity, Guotai Medical ETF recorded an intraday turnover rate of 4.59%, with a trading volume of 104 million yuan. Over a longer horizon, as of May 20, the ETF's average daily turnover over the past year stood at 61.9206 million yuan.
Regarding scale, the latest AUM of Guotai Medical ETF reached 2.180 billion yuan, ranking 2/4 among comparable funds. (Data source: Wind)
In terms of capital inflows, the latest capital inflow and outflow for Guotai Medical ETF were flat. Looking at a longer timeframe, over the past five trading days, the total net inflow amounted to 30.1644 million yuan. (Data source: Wind)
Data shows that leveraged funds continue to position themselves. The net margin purchase amount for Guotai Medical ETF on the previous trading day reached 1.9548 million yuan, and the latest margin balance stood at 70.9737 million yuan. (Data source: Wind)
In terms of return capability, as of May 20, 2026, since its inception, Guotai Medical ETF achieved a highest single-month return of 30.02%, a longest consecutive gaining streak of five months with a cumulative gain of 23.83%, and an average return of 5.67% during up months. As of May 20, 2026, the ETF's annualized excess return over its benchmark over the past year was 1.77%, ranking in the top 2/4 among comparable funds.
In terms of drawdown, as of May 20, 2026, Guotai Medical ETF's relative drawdown versus its benchmark since the beginning of the year was 0.06%, indicating relatively low drawdown risk among comparable funds.
In terms of fees, Guotai Medical ETF has a management fee rate of 0.50% and a custody fee rate of 0.10%.
In terms of tracking accuracy, as of May 20, 2026, Guotai Medical ETF's tracking error since the beginning of the year was 0.021%, indicating relatively high tracking precision among comparable funds.
From a valuation perspective, the latest price-to-earnings ratio (PE-TTM) of the CSI Medical Index, which Guotai Medical ETF tracks, is only 28.15 times, placing it at the 1.17th percentile over the past year—meaning the valuation is lower than that of over 98.83% of the time in the past year, indicating a historically low level.
Guotai Medical ETF closely tracks the CSI Medical Index. The CSI Medical Index selects securities of listed companies in the healthcare and pharmaceutical industry whose businesses involve medical themes such as medical devices, medical services, and medical information technology as index constituents, in order to reflect the overall performance of listed company securities in the medical theme.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- CapitaLand Ascendas REIT Officially Launches S$1.4 Billion Geneo Project to Revitalise Singapore Science Park
- Daily Report on Hong Kong-Listed LLM Concept Stocks (May 22, 2026)
- Large Model Concept Stocks Volatility: Intensive Product Releases and Comprehensive Multi-functional Application Landscape Unfold
- Diagens-B (02526.HK): Core Product AI AutoVision® Obtains NMPA Class III Medical Device Registration Certificate
- Samsung Blockchain Technologies ETF (03171.HK) Rises 3.35% to HKD 48.100